Literature DB >> 17669411

C-reactive protein and atherogenesis: from fatty streak to clinical event.

Radjesh J Bisoendial1, John J P Kastelein, Erik S G Stroes.   

Abstract

In recent years, it has become increasingly clear that arterial inflammation represents a key feature determining the course of atherogenesis. The consecutive stages in the evolution of atherosclerotic lesions are respectively, plaque buildup and growth, and destabilization, predisposing to plaque rupture and intravascular thrombosis. This chain of events leading from lesion formation to clinical events has been carefully elucidated during the last three decades. C-reactive protein (CRP) has been directly implicated in the pathogenesis of atherosclerosis. In the present review, we will focus on a potentially causal role of CRP during the various stages of atherogenesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17669411     DOI: 10.1016/j.atherosclerosis.2007.04.053

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  31 in total

1.  Putting cardiovascular risk into perspective: A view from a pharmacist patient.

Authors:  Tom Smiley
Journal:  Can Pharm J (Ott)       Date:  2013-03

2.  Norman Cousins Lecture. Mechanisms of cytokine-induced behavioral changes: psychoneuroimmunology at the translational interface.

Authors:  Andrew H Miller
Journal:  Brain Behav Immun       Date:  2008-09-03       Impact factor: 7.217

Review 3.  Adipose tissue and vascular inflammation in coronary artery disease.

Authors:  Enrica Golia; Giuseppe Limongelli; Francesco Natale; Fabio Fimiani; Valeria Maddaloni; Pina Elvira Russo; Lucia Riegler; Renatomaria Bianchi; Mario Crisci; Gaetano Di Palma; Paolo Golino; Maria Giovanna Russo; Raffaele Calabrò; Paolo Calabrò
Journal:  World J Cardiol       Date:  2014-07-26

Review 4.  Clinical utility of novel biomarkers for cardiovascular disease risk stratification.

Authors:  Maurizio Averna; Davide Noto
Journal:  Intern Emerg Med       Date:  2012-10       Impact factor: 3.397

5.  Ethnic/racial differences in the association between social support and levels of C-reactive proteins in the North Texas Heart Study.

Authors:  Bert N Uchino; John M Ruiz; Timothy W Smith; Joshua M Smyth; Daniel J Taylor; Matthew Allison; Chul Ahn
Journal:  Psychophysiology       Date:  2016-01       Impact factor: 4.016

Review 6.  Cytokines and glucocorticoid receptor signaling. Relevance to major depression.

Authors:  Thaddeus W W Pace; Andrew H Miller
Journal:  Ann N Y Acad Sci       Date:  2009-10       Impact factor: 5.691

7.  Association of a single nucleotide polymorphism in the C-reactive protein gene (-286) with susceptibility to Plasmodium falciparum malaria.

Authors:  Hayder A Giha; Amre Nasr; Mattias Ekström; Elisabeth Israelsson; Gishanthi Arambepola; David Arnot; Thor G Theander; Marita Troye-Blomberg; Klavs Berzins; Per Tornvall; Gehad ElGhazali
Journal:  Mol Med       Date:  2009-11-17       Impact factor: 6.354

Review 8.  Inflammation and cardiovascular disease: from pathogenesis to therapeutic target.

Authors:  Enrica Golia; Giuseppe Limongelli; Francesco Natale; Fabio Fimiani; Valeria Maddaloni; Ivana Pariggiano; Renatomaria Bianchi; Mario Crisci; Ludovica D'Acierno; Roberto Giordano; Gaetano Di Palma; Marianna Conte; Paolo Golino; Maria Giovanna Russo; Raffaele Calabrò; Paolo Calabrò
Journal:  Curr Atheroscler Rep       Date:  2014-09       Impact factor: 5.113

9.  Serum amyloid P (SAP) is associated with impaired brachial artery flow-mediated dilation in chronically HIV-1 infected adults on stable antiretroviral therapy.

Authors:  Nath Zungsontiporn; Lishomwa C Ndhlovu; Brooks I Mitchell; James H Stein; Kalpana J Kallianpur; Beau Nakamoto; Sheila M Keating; Philip J Norris; Scott A Souza; Cecilia M Shikuma; Dominic C Chow
Journal:  HIV Clin Trials       Date:  2015-11

10.  The relationship between brachial ankle pulse wave velocity and complement 1 inhibitor.

Authors:  Yong Min Chae; Jong Kwon Park
Journal:  J Korean Med Sci       Date:  2009-09-23       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.